KKKārlis Kupčs

Kārlis Kupčs

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kārlis Kupčs has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Improved safety of intracranial aneurysm coiling with OPTIMA™: Results of the INSTANT study

    by Laurent Pierot, Gaultier Marnat, Roberto Riva, Jean-Christophe Gentric, Olivier Levrier, Karlis Kupcs, Charlotte Barbier, Aurelio Vega Astudillo, Remy Beaujeux, Jose Luis Lopez-Martinez, et al.

    Coiling remains a widely used, first-line endovascular treatment for intracranial aneurysms. However, recent large-scale evaluations are limited since the ARETA study, which assessed the safety and efficacy of aneurysm coiling in patients treated between 2013 - 2015. A detailed analysis of the INSTANT study is presented, which provides recent data on endovascular treatment of intracranial aneurysms with the OPTIMA™ coil system (Balt). INSTANT is a European, non-interventional, prospective study that assessed patients with ruptured, unruptured, or recanalized aneurysms treated with OPTIMA™. The primary endpoint was the morbi-mortality of patients treated with OPTIMA™ at 30 days, with an additional assessment at 12 months as a secondary endpoint. From April 2019 to September 2022, 294 patients (56.3±12.0 years, 186 women [63.3%]) were enrolled in 18 European centers. Aneurysms were acutely ruptured in 45.2% of cases (N=133/294) and unruptured/recanalized in 54.8% (N=161/294). The overall mortality at 30 days was 0.0% in patients with unruptured aneurysms and 3.0% (N=4/133, [95% CI:0.1-5.9]) in those with ruptured aneurysms, which were all related to SAH and its complications. Overall, morbidity at 30 days was 1.2% (N=2/161, [95% CI:0.0-3.0]) in patients with unruptured aneurysms and 21.1% (N=28/133, [95% CI:14.1-28.0]) in patients with ruptured aneurysms. No deaths or adverse events resulting in morbidity were related to OPTIMA™ or the procedure (0.0%). In the INSTANT study, treatment of intracranial aneurysms with the OPTIMA™ coil system showed low morbidity and mortality at 30 days and 12 months, unrelated to the device or procedure.

  • Open Access

    Juvenile Nasopharyngeal Angiofibroma in an Adult Patient: A Rare Presentation with Fahr Syndrome and Multiple Comorbidities—A Case Report and Literature Review

    by Sigita Zālīte, Karīna Čudare, Kalvis Vērzemnieks, Sergejs Pavlovičs, Kārlis Kupčs, Ingus Vilks, Tatjana Tone, Inese Briede, Arturs Balodis

    Background and Clinical Significance: Juvenile nasopharyngeal angiofibroma (JNA) is a benign but locally aggressive vascular tumor, classically affecting adolescent males. Diagnosis in adulthood is exceptionally uncommon and may mimic other vascular or malignant nasopharyngeal lesions. This patient also had chronic hypocalcemia with Fahr-like intracranial calcifications secondary to long-standing postoperative hypoparathyroidism after thyroid carcinoma treatment. To our knowledge, this coexistence has not been previously reported. Case Presentation: A 34-year-old Caucasian male with papillary thyroid carcinoma treated with total thyroidectomy developed postoperative hypoparathyroidism with chronic hypocalcemia and Fahr-like intracranial calcifications. During admission for acute respiratory insufficiency due to tracheostomy dysfunction, imaging revealed a 37 × 33 × 32 mm heterogeneous, hypervascular nasopharyngeal mass extending into the right pterygopalatine fossa (PPF) with bone remodeling and focal bony dehiscence. Digital subtraction angiography demonstrated a markedly hypervascular tumor, predominantly supplied by branches of the right internal maxillary artery (via the sphenopalatine artery). Endoscopic resection was performed, and histopathology confirmed JNA. Most JNA cases occur between 7 and 19 years of age; presentations in men older than 30 years are rare and often generate diagnostic uncertainty, particularly when differentiating from nasopharyngeal carcinoma or other lesions. In adults, magnetic resonance imaging/computed tomography for assessment of local extent and angiography for vascular mapping are key to minimizing hemorrhagic risk. The concurrent endocrine disorder emphasizes the need for multidisciplinary perioperative metabolic optimization, without implying a pathophysiological link. Conclusions: This report illustrates JNA diagnosed in adulthood in a male with Fahr-like intracranial calcifications secondary to chronic hypoparathyroidism. It highlights the necessity of considering JNA in the differential diagnosis of hypervascular nasopharyngeal masses in adults, especially in patients with complex comorbidities.


  • Open Access

    Hypoperfusion Intensity Ratio as an Independent Predictor of Functional Outcome After Mechanical Thrombectomy for Large Vessel Occlusion Stroke

    by Dagnija Grabovska, Arturs Balodis, Arvīds Bušs, Madara Ratniece, Roberts Šamanskis, Evija Miglāne, Kārlis Kupčs, Kristaps Jurjāns, Arta Grosmane, Sigita Zālīte, et al.

    Background and Objectives: Acute ischemic stroke (AIS) caused by large vessel occlusion (LVO) remains a major cause of disability and mortality. Mechanical thrombectomy (MT) improves outcomes, but recovery varies. This study assessed the prognostic value of hypoperfusion intensity ratio (HIR), collateral circulation, and other clinical/imaging factors. Materials and Methods: This retrospective cohort study included 96 LVO patients treated with MT with or without intravenous thrombolysis (IVT) between 2020 and 2024 at a tertiary hospital. Inclusion required multimodal CT (CT, CTA, CTP) and clinical data (NIHSS, mRS). HIR, core volume, CBV index, mismatch ratio, and collateral status were evaluated using artificial intelligence (AI)-based software. Univariate/multivariate logistic regression identified predictors of poor outcome (mRS > 3 at 90 days). Results: Lower HIR (p < 0.001). Multivariate analysis identified HIR, initial NIHSS, and procedure duration as independent predictors of poor outcome. CTP-derived core volume, cerebral blood volume index, and mismatch ratio were also significant predictors. ROC analysis showed the highest AUC for core volume (0.810). Diabetes mellitus was associated with a worse prognosis compared to other clinical factors. Conclusions: HIR and collateral status are independent predictors of functional recovery after MT. CTP-derived core volume and CBV index have strong prognostic value. AI-based perfusion analysis supports patient selection and risk stratification.

  • Open Access

    A Forgotten Rare Cause of Unilateral Basal Ganglia Calcinosis Due to Venous Angioma and Complicating Acute Stroke Management: A Case Report

    by Arturs Balodis, Sintija Strautmane, Oskars Zariņš, Kalvis Verzemnieks, Jānis Vētra, Sergejs Pavlovičs, Edgars Naudiņš, Kārlis Kupčs

    Background: Unilateral basal ganglia calcinosis (BGC) is a rare radiological finding that can be diagnosed on computed tomography (CT) and magnetic resonance imaging (MRI) but often presents challenges for clinicians and radiologists in determining its underlying cause. So far, only a few potential causes that could explain unilateral BGC have been described in the literature. Case Report: A 54-year-old Caucasian male was admitted to a tertiary university hospital due to the sudden onset of speech impairment and right-sided weakness. The patient had no significant medical history prior to this event. Non-enhanced computed tomography (NECT) of the brain revealed no evidence of acute ischemia; CT angiography (CTA) showed acute left middle cerebral artery (MCA) M2 segment occlusion. CT perfusion (CTP) maps revealed an extensive penumbra-like lesion, which is potentially reversible upon achieving successful recanalization. However, a primary neoplastic tumor with calcifications in the basal ganglia was initially interpreted as the potential cause; therefore, acute stroke treatment with intravenous thrombolysis was contraindicated. A follow-up CT examination at 24 h revealed an ischemic lesion localized to the left insula, predominantly involving the left parietal lobe and the superior gyrus of the left temporal lobe. Subsequent gadolinium-enhanced brain MRI revealed small blood vessels draining into the subependymal periventricular veins on the left basal ganglia. Digital subtraction angiography was conducted, confirming the diagnosis of venous angioma. Conclusions: Unilateral BGC caused by venous angioma is a rare entity with unclear pathophysiological mechanisms and heterogeneous clinical presentation. It may mimic conditions such as intracerebral hemorrhage or hemorrhagic brain tumors, complicating acute stroke management, as demonstrated in this case. Surrounding tissue calcification may provide a valuable radiological clue in diagnosing venous angiomas DVAs and vascular malformations.


  • Open Access

    A Forgotten Rare Cause of Unilateral Basal Ganglia Calcinosis Due to Venous Angioma, and Complicating Acute Stroke Management: A Case Report and Literature

    by Arturs Balodis, Sintija Strautmane, Oskars Zariņš, Kalvis Verzemnieks, Jānis Vētra, Sergejs Pavlovičs, Edgars Naudiņš, Kārlis Kupčs

    Background. Unilateral basal ganglia calcinosis (BGC) is a rare radiological finding that can be diagnosed on CT and MRI but often presents challenges for clinicians and radiologists in determining its underlying cause. So far, only a few potential causes that could explain unilateral basal ganglia calcification have been described in the literature. Case Report. A 54-year-old Caucasian male was admitted to a tertiary university hospital due to the sudden onset of speech impairment and right-sided weakness. The patient had no significant medical history prior to this event. Non-enhanced computed tomography (NECT) of the brain revealed no evidence of acute ischemia, CTA shows acute MCA M2 segment occlusion. CT perfusion (CTP) maps reveal an extensive penumbra-like lesion, which is potentially reversible upon achieving successful recanalization. However, a primary neoplastic tumor with calcifications in the basal ganglia was initially interpreted as the potential cause, therefore, acute stroke treatment with intravenous thrombolysis was contraindicated. A follow-up CT examination at 24 hours revealed an ischemic lesion localized to the left insula, predominantly involving the left parietal lobe and the superior gyrus of the left temporal lobe. Subsequent gadolinium-enhanced brain MRI revealed small blood vessels draining into the subependymal periventricular veins on the left basal ganglia. Digital subtraction angiography was conducted, confirming the diagnosis of venous angioma. Conclusion. Unilateral BGC caused by venous angioma is a rare entity with unclear pathophysiological mechanisms and heterogeneous clinical presentation. It may mimic conditions such as intracerebral hemorrhage or hemorrhagic brain tumors, complicating acute stroke management, as demonstrated in this case. Surrounding tissue calcification may provide a valuable radiological clue in diagnosing venous angiomas DVAs and vascular malformations.

  • Open Access

    The Stream Device—A Retrospective Review of 51 Cases

    by Karlis Kupcs, Patricija Sproge, Katrina Kupca, Pervinder Bhogal

    Mechanical thrombectomy is the gold-standard treatment for patients that have suffered large-vessel occlusion (LVO) stroke. Various different stent-retrievers, aspiration catheters, and techniques have been developed to perform this procedure. We present our initial results regarding the Stream device. Materials and Methods: We performed a retrospective review of a prospectively maintained database at our high-volume centre to identify all patients treated with the Stream device between February 2021 and January 2023. We recorded baseline demographics, NIHSS, ASPECT scores, eTICI scores, complications, and 90-day mRS. Results: We identified 51 patients, 49.0% of whom were male (n = 25), with a median age of 73 (range: 51–89) and a median NIHSS score of 17 (range 4–22), and 68.6% received IV tPA. The median ASPECT score was 10 (range 6–10). Hyperdense clots were seen in 34 cases (66.7%), with a mean clot length of 12 ± 6.2 mm (range 2–26 mm). Clots were located in the anterior circulation in 49 patients. The standard Stream device was used in 78.4% of cases, with Stream 17 being used in 19.6% of cases. The FPE was observed in 25.5% of cases (n = 13), with the mFPE being seen in 31.4% of cases (n = 16). A final eTICI score of ≥2b was achieved in 90.2% of cases (n = 46), and eTICI 2c/3 was seen in 84.3% of cases (n = 43). Furthermore, 24 h CT scans showed that the median ASPECT score was 8 (range 0–10). Good functional outcomes at 90 days (mRS ≤ 2) were achieved in 21.6% of cases (n = 11). Conclusions: The Stream device shows acceptable rates of FPE and mFPE compared to existing devices. Further larger studies are required alongside an understanding of the optimal technique for this device’s use.